More articles from Volume 43, Issue 1, 2014
PROGNOSTIČKI ZNAČAJ GLEASON SCORE-A 7 (3+4) I GLEASON SCORE-A 7 (4+3) U ADENOKARCINOMU PROSTATE U ODNOSU NA KLINIČKI STADIJUM, TKIVNI ANDROGEN STATUS I STEPEN NEUROENDOKRINE DIFERENCIJACIJE
KLINIČKE MANIFESTACIJE OSTEOARTRITISA KOLENIH ZGLOBOVA
DNA identification of war and mass catastrophies victims
Electrocardiography changes in patients with acute myocardial infarction in late hospital phase
SINDROM OPSTRUKCIONE APNEJE U SPAVANJU KOD DECE
POVEĆANA VREDNOST KARDIJALNOG TROPONINA I U HIPERTROFIČNOJ KARDIOMIOPATIJI I DIJASTOLNOJ SRČANOJ SLABOSTI
,
S. Lazic
,
D. Rasic
,
B. Lazic
,
Z. Marcetic
,
V. Peric
,
M. Sipic
S. Pajovic
Abstract
Keywords
References
1.
Apple F, Parvin C, Buechler K, Christenson R, Wu A, Jaffe A. Validation of the 99th percentile cutoff independent of assay imprecision(CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin Chem. 2005;2198–200.
2.
Mingels A, Jacobs L, Kleijnen V, Laufer E, Winkens B, Hofstra L, et al. Cardiac troponin elevations, using highly sensitive assay, in recreational running depend on running distance. Clin Res Cardiol. 2010;385–91.
3.
Ng S, Krishnaswamy P, Morrisey R, Clopton P, Fitzgerald R, Maised A. Mitigation of the clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischaemia using serial testing of multiple cardiac markers. Am J Cardiol. 2001;994–9.
4.
Missov E, Calzolari C, Pan B. Circulating cardiac troponin I in severe congestive heart failure. Circulation. 1997;2953–8.
5.
Peacock W, I, Teresa De M, Marco M, Gregg C Fonarow M, Direcks D. Cardiac Troponin and Outcome in Acute Heart Failure. N Engl Med. 2008;2117–26.
6.
Mc Kee P, Castelli W. The natural hystory of congestive heart failure: the Framingham study. N Engl Med. 1971;1441–6.
7.
Aslam F, Hague A, Foody J, Shironi J. The frequency and functional impact of overlapping hypertension on hypertrophic cardiomyopathy: a single-center experience. J Clin Hypertens(Greenwich). 2010;(4):240–5.
8.
Hamwi S, Sharma A, Weissman N, Goldstein S, Apple S, Canos D. Troponin I elevation in patienths with increased left ventricular mass. Am J Cardiol. 2003;88–90.
9.
Biener M, Mueller M, Vafaie M, Jaffe A, Widera C, Katus H, et al. Diagnostic performance of rising, falling, or rising and falling kinetic changes of high-sensitivity cardiac troponin T in an unselected emergency department population. Eur Heart J Acute Cardiovasc Care. 2013;(4):314–22.
10.
Normann J, Mueller M, Biener M, Vafaie M, Katus K, Giannitsis E. Effect of older age on diagnostic and prognostic performance of high-sensitivity troponin T in patients presenting to an emergency department. Am Heart J. 2012;(5):698–705.
11.
Zethelius B, Md P, Johnston N, Md; Pervenge, Md P. Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Uear old man. Circulation. 2006;1071–8.
12.
Dinh V, Nickl W, Futh R, Lankisch M, Hess G, Zdunek D, et al. High sensitive troponin T and heart fathy acid binding protein: Novel biomarker in heart failure with normal ejection fraction? A cross-sectional study. BMC Cardiovascular Disorders. 2011;41.
13.
Boer D, Luk R, Jaaraswa D, Van Der Meer T, Voors P, Hillage A, et al. Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med. 2011;60–8.
14.
Wallace T, Shuaib M, Abdulah M, Mark M, Drayner H, Md M, et al. Prevalence and Determinants of Troponin T Elevation in the General Population. Circulation. 2006;1958–65.
15.
Vinau S, Mahajan, Md, Phd P, Jarolim, Md P. How to Interpret Elevated Cardiac Troponin Levels. Circulation. 2011;2350–4.
16.
Braunwald E. Biomarkers in heart failure. N Engl Med. 2008;2148–59.
17.
Sundstrom J, Ingelsson E, Berglund L, Zethellius B, Lind L, Venge P, et al. Cardiac troponin I and risk of heart failure: a community based cohort study. Eur Heart J. 2009;773–81.
18.
Latini R, Masson S, Anand S, Missov E, Carlson M, Vago T, et al. Val-HeFT Investigators. Prognostic value of Very low plasma contrentrations of troponin T in patients with stable heart failure. Circulation. 2007;1242–9.
19.
Cop W, Gottdiener J, De Filipi C, Barasch E, Seliger S, Jenny N, et al. Cardiac microinjury measured by troponin T predict collagen metabolism in adults > 65 years with heart failure. Circ Heart Fail. 2012;406–13.
20.
Klein Gunnlwiek J, Van De Leur J. Elevates troponin T contrentations in critically ill patients. Intensive Care Med. 2003;(12):2317–22.
21.
Simone D, Greco G, Mureddu R, G. Relation of left ventricular diastolic properties to systolic function in arterial hypertension. Circulation. 2000;152–7.
22.
Lazic S, Pajovic S, Stolic R, Celic D. Acute coronary syndrome without ST segment elevation in hypertrophic cardiomyopathy and normal coronary angiogram: a case report. Cardiol Croat. 2013;(9):282.
23.
Lazic S, Pajovic S, Celic D, Sipic M. Normal coronary arteries and myocardial infarction-case report. EuroThrombosis Summit. 2012;20.
24.
Arlati S, Brenna S, Prencipe A, Marocchi G, Casella M, Lanzani C, et al. Myocardial necrosis in ICU patients with acute non-cardiac disease: a prospective study. Intensive Care Med. 2000;31–7.
25.
Angheloiu G, Rp D, Ravakhah K. Etiology of troponin I elevation in patients with congestive heart failure and low clinical suspicion of myocardial infarction. Resuscitation. 2004;(2):195–201.
26.
Eggers K, Lind L, Ahlestrom H, Bjeruer T, Barbier C, Larsson A, et al. European Heart Journal. 2008;2252–8.
27.
Kubo T, Kitaoka H, Yamanaka S, Hirota T. Significance of High Sensitivity Cardiac Troponin T in Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2013;(14):1252–9.
28.
Bakshi T, Choo M, Edwards C, Scott A, Hart H, Armstrong G. Causes of elevates troponin I with a normal coronary angiogram. Internal Medicine Journal. (11):520–5.
Citation
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
